Chairman Wang Linbing increased his holding of S HARBOURHOLD (01663) by 3.226 million shares at a price of 0.086 Hong Kong dollars per share.

18:55 02/04/2026

On April 1st, Chairman of the Board Wang Linbing increased his holdings in Han Harbor Holdings (01663) by 3,226,000 shares, with a price of 0.088 Hong Kong dollars per share, for a total amount of approximately 28.39 million Hong Kong dollars.

The latest data from the Hong Kong Stock Exchange shows that on April 1st, Chairman of the Board Wang Linbing increased his holdings of S HARBOURHOLD (01663) by 3.226 million shares, at a price of 0.088 Hong Kong dollars per share, with a total amount of approximately 283,900 Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.527 billion, with a latest shareholding ratio of 61.97%. This transaction involves another related party: Chen Xiangling.

China Securities Co., Ltd. reviews the A-share market in the first quarter of 2026: This bull market is more forward-looking in terms of regulation and will take timely measures to address overheated trading.

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.

Subsidiary company of Shenzhen Nanshan Power (000037.SZ) plans to invest in the construction of a 300MW/600MWh independent energy storage power station in the Cuiheng New Area of Zhongshan City (Phases Two and Three) project.

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.